AsOf

Regeneron Pharmaceuticals · cash and equivalents3,659,100,000 United States dollar

valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted

What the statuses mean

Valid from
2026-09-30
Valid until
still holds
Published
2026-10-30
Recorded by AsOf
2026-11-08
Checked
2026-11-08 · parsed from the SEC filing
Confidence
0.95

Sources

Cite this claim

Each form names the value, its as-of date (2026-09-30), the day you read it (2026-11-09), the claim's stable URL and id and its primary source. The URL never changes: a superseded claim stays at the same address.

Plain text
AsOf. "Regeneron Pharmaceuticals cash and equivalents: 3,659,100,000 United States dollar", as of 2026-09-30. Claim clm_5EBA4C72A92F, https://asof.is/claim/clm_5EBA4C72A92F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm.
APA
AsOf. (2026). Regeneron Pharmaceuticals cash and equivalents: 3,659,100,000 United States dollar (as of 2026-09-30) [Record clm_5EBA4C72A92F]. Retrieved November 9, 2026, from https://asof.is/claim/clm_5EBA4C72A92F (source: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm)
BibTeX
@misc{asof_clm_5EBA4C72A92F,
  author = {AsOf},
  title = {Regeneron Pharmaceuticals cash and equivalents: 3,659,100,000 United States dollar},
  year = {2026},
  howpublished = {\url{https://asof.is/claim/clm_5EBA4C72A92F}},
  note = {Claim clm\_5EBA4C72A92F, as of 2026-09-30; source: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm},
  urldate = {2026-11-09}
}

Supersedes

On the record

/claim/clm_5EBA4C72A92F.md/v1/claims/clm_5EBA4C72A92Fsubmit a correction